BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 25948277)

  • 1. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity.
    Baimel C; Borgland SL
    J Neurosci; 2015 May; 35(18):7295-303. PubMed ID: 25948277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
    Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
    Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin modulation of drug-induced synaptic plasticity.
    Baimel C; Borgland SL
    Prog Brain Res; 2012; 198():123-31. PubMed ID: 22813972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.
    Borgland SL; Taha SA; Sarti F; Fields HL; Bonci A
    Neuron; 2006 Feb; 49(4):589-601. PubMed ID: 16476667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.
    Richardson KA; Aston-Jones G
    J Neurosci; 2012 Mar; 32(11):3809-17. PubMed ID: 22423101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA receptors in the midbrain play a critical role in dopamine-mediated hippocampal synaptic potentiation caused by morphine.
    Hu L; Jing XH; Cui CL; Xing GG; Zhu B
    Addict Biol; 2014 May; 19(3):380-91. PubMed ID: 23163242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous opioid-induced neuroplasticity of dopaminergic neurons in the ventral tegmental area influences natural and opiate reward.
    Pitchers KK; Coppens CM; Beloate LN; Fuller J; Van S; Frohmader KS; Laviolette SR; Lehman MN; Coolen LM
    J Neurosci; 2014 Jun; 34(26):8825-36. PubMed ID: 24966382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons.
    Hausknecht K; Shen YL; Wang RX; Haj-Dahmane S; Shen RY
    J Neurosci; 2017 Jun; 37(24):5798-5808. PubMed ID: 28476947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
    Mahler SV; Smith RJ; Aston-Jones G
    Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.
    Wang B; You ZB; Wise RA
    Biol Psychiatry; 2009 May; 65(10):857-62. PubMed ID: 19251246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL; Storm E; Bonci A
    Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons.
    Thompson JL; Borgland SL
    Biol Psychiatry; 2013 May; 73(9):860-8. PubMed ID: 23305991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
    Zarepour L; Fatahi Z; Sarihi A; Haghparast A
    Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours.
    Thomas CS; Mohammadkhani A; Rana M; Qiao M; Baimel C; Borgland SL
    Neuropsychopharmacology; 2022 Feb; 47(3):728-740. PubMed ID: 34663867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
    Narita M; Nagumo Y; Hashimoto S; Narita M; Khotib J; Miyatake M; Sakurai T; Yanagisawa M; Nakamachi T; Shioda S; Suzuki T
    J Neurosci; 2006 Jan; 26(2):398-405. PubMed ID: 16407535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-induced synaptic plasticity in the VTA is reversed by HDAC inhibition.
    Authement ME; Langlois LD; Kassis H; Gouty S; Dacher M; Shepard RD; Cox BM; Nugent FS
    J Neurophysiol; 2016 Sep; 116(3):1093-103. PubMed ID: 27306674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences.
    Moorman DE; Aston-Jones G
    J Neurosci; 2010 Nov; 30(46):15585-99. PubMed ID: 21084614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
    Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
    Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine Exposure Enhances the Activity of Ventral Tegmental Area Dopamine Neurons via Calcium-Impermeable NMDARs.
    Creed M; Kaufling J; Fois GR; Jalabert M; Yuan T; Lüscher C; Georges F; Bellone C
    J Neurosci; 2016 Oct; 36(42):10759-10768. PubMed ID: 27798131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin A induced antinociception in the ventral tegmental area involves D1 and D2 receptors in the nucleus accumbens.
    Yazdi-Ravandi S; Razavi Y; Haghparast A; Goudarzvand M; Haghparast A
    Pharmacol Biochem Behav; 2014 Nov; 126():1-6. PubMed ID: 25179164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.